Find and Pitch Jounalists, Get Your Story Covered

Tags: BioPharma, Daily, Health IT, MedCity Influencers

	Profile	Recent Articles on Subject
1	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Who’s winning in biotech’s tight market? - 6 days ago Pharma’s ‘it’ therapy — a new drug class gaining steam - 15 days ago Is anyone taking the world’s priciest drugs? - 20 days ago Neuro drugs are still faltering, despite rising investment - about 2 months ago Up-and-comers look for an edge in the bustling ADC field - 3 months ago Pharma’s R&D gamble: picking pipeline winners in a risky field - 3 months ago Where competition is heating up in pharma - 4 months ago The biggest questions hanging over pharma in 2024 - 8 months ago PharmaVoice’s Crystal Ball: What’s next in drug innovation and clinical trials - 8 months ago PharmaVoice 100s: Entrepreneurs - 11 months ago
2	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	BioMarin’s big day today - 15 days ago
3	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Pharmacy Focus: Alzheimer Drug Pipeline Expands, Promising Therapies in Development - 27 days ago Five Quick Facts to Know About Biosimilars - about 1 month ago Key Market Trends for the Current Specialty Drug Pipeline - 11 months ago
4	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	BMS’ KarXT nears schizophrenia approval, but AbbVie and others wait in the wings - about 1 month ago Can BioNTech sustain a post-COVID mRNA pipeline? Oncology is the next hope. - about 1 month ago A potential MS ‘game changer’ could bring more safety to the table — even against viruses - about 1 month ago In a Duchenne market beset by problems, Capricor data marks a bright spot - about 1 month ago Behind the powerful computations, AI’s role in pharma is still beset by challenges - 3 months ago 4 offbeat biotechs making a splash in the life sciences - 5 months ago As antimicrobial resistance looms large, a nonprofit teams up with Big Pharma to intervene - 6 months ago These biotech hotspots are ripe for IPOs - 6 months ago COVID vaccine giants Moderna and Pfizer employ divergent tactics for the next chapter - 6 months ago Black Diamond looks to outwit cancer mutations - 7 months ago
5	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	Is pharma still fearful of the Inflation Reduction Act? - about 1 month ago The biotech news you missed this week - 2 months ago STAT+: More tumult at BIO amid the company’s fourth CEO in four years - 4 months ago How resurrecting extinct species might impact medicine - 6 months ago Lawmakers want to add more Chinese biotechs to defense list - 6 months ago Novartis is building a new radioligand plant in China - 10 months ago
6	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Flagship Pioneering Launches Startup Abiologics to Advance New Class of Biologic Drugs - about 2 months ago
7	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	A biotech’s binary bet ends badly - 3 months ago
8	Damian Garde STAT News Biotech reporter at STAT. Open to messages. biotechnologyjournalism	Gas prices are hurting biotech - 5 months ago STAT+: 3 trends to watch in biotech in 2024 - 9 months ago
9	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about biotech startups, Pfizer’s RSV vaccine, and more - 5 months ago STAT+: Pharmalittle: We’re reading about Biocon eyeing weight loss drugs, Sanofi layoffs, and more - 5 months ago STAT+: Pharmalittle: We’re reading about Boehringer biosimilar frustrations, FTC warnings, and more - 6 months ago STAT+: Pharmalittle: We’re reading about Lilly selling drugs directly, UCB leaving BIO, and more news - 9 months ago STAT+: Pharmalittle: FDA approvals rebound, abortion pill orders rise, and more news - 9 months ago STAT+: Pharmalittle: Weight loss drugs are being paired with bariatric surgery; Carl Icahn plans to oust Illumina directors - 9 months ago STAT+: Pharmalittle: Pfizer is leaving the BIO trade group; CVS drug-pricing plan may not lower costs for consumers - 10 months ago STAT+: Pharmalittle: Bioscience job market is upside down; Sanofi and Regeneron’s blockbuster Dupixent may find bigger market - 10 months ago
10	Alexandra Pecci Pharma Voice Leading community for life sciences leaders. Washington, D.C. pharmaceuticalslife sciencescommunity building	Ferring’s microbiome and gene therapy firsts take the company beyond reproductive health - 7 months ago 4 biotechs to watch in 2024 - 7 months ago 5 noteworthy pharma AI investments in 2023 - 9 months ago Biopharma’s top 5 IPOs of 2023 (so far) - 10 months ago The power of genomics-based healthcare remains largely untapped - 10 months ago Cidara’s J&J-partnered immunotherapy could target flu and cancer - 11 months ago To close the pediatric innovation gap, this biotech has to think differently - 11 months ago Where have all the unicorns gone? A look at 4 billion-dollar biotechs - 12 months ago

Journalists covering Biopharmaceuticals